The CEO of obesity drug manufacturer Novo Nordisk and heads of other Danish companies were expected to discuss preparations for a possible trade conflict with the United States over Greenland with Denmark's Prime Minister Mette Frederiksen on Thursday.

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs for mandatory price negotiations.

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland could disrupt one export that is wildly popular in America:

Denmarks Prime Minister Mette Frederiksen has called for a meeting with the nations business leaders after U.S. President-elect Donald Trump suggested possible military or economic action, including tariffs,

Danish business leaders, including Novo Nordisk's CEO, met with Prime Minister Mette Frederiksen to address potential U.S.-Denmark trade conflicts over Greenland. This follows U.S. President-elect Trump's unclear stance on economic or military actions regarding Greenland.

Denmark is the latest in a series of countries that President-elect Donald Trump has threatened with tariffs — joining a list that includes the 26 other nations of the European Union, as well as Canada and Mexico.

Denmark's Prime Minister Mette Frederiksen initiated discussions with business leaders in response to U.S. President-elect Donald Trump's remarks on acquiring Greenland. Trump suggested economic pressure on Denmark if it resisted.

In her call with Trump, Mette Frederiksen also reiterated the Greenland PM's comments that it was "not for sale"

As CNN previously reported, Danish officials fear Trump is much more serious about acquiring Greenland than he was in his first term. It’s also gotten the attention of officials at Novo Nordisk. “We will follow the situation closely,” a company ...

Mexico and China — as he has increasingly spoken of the U.S. taking Greenland off Denmark’s hands. Danish multinational pharmaceutical giant Novo Nordisk is the sole owner of semaglutide ...